微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -4.42% | -227.41% | -580% | 125/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | -0.65% | -155.08% | 90.28% | 111/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | -6.69% | 12.66% | -869.57% | 116/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | -0.69% | 34.91% | 48.89% | 108/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | -1.35% | -14.41% | -214.41% | 114/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 1.18% | 321.43% | 115.4% | 66/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | -7.66% | -28.09% | -622.64% | 118/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | -1.06% | -123.61% | 10.17% | 112/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | -1.18% | -138.31% | -521.43% | 115/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 0.28% | -82.61% | 104.68% | 98/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | -5.98% | -1145.83% | -233.18% | 119/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 4.49% | 498.67% | 45.78% | 72/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 3.08% | 1000% | 91.3% | 69/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 1.61% | 45.05% | 435.42% | 71/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | -0.48% | -109.76% | -164% | 115/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 0.75% | -89.92% | 167.86% | 107/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 0.28% | -94.79% | -74.77% | 112/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 1.11% | -57.95% | -77.44% | 83/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 4.92% | -89.59% | -33.87% | 109/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 7.44% | -83.74% | 38.55% | 79/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 5.37% | -85.24% | 103.41% | 76/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 2.64% | -63.13% | -94.41% | 57/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 47.26% | 350.1% | 3.26% | 20/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 45.77% | 379.77% | 25.81% | 10/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 36.38% | 694.32% | 408.1% | 14/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 7.16% | 153% | -31.81% | 9/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 10.5% | 0.96% | 10.06% | 77/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 9.54% | 1.6% | 108.3% | 30/141 | 10.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 4.58% | -20.35% | 61.84% | 49/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 2.83% | -22.68% | -72.79% | 21/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 10.4% | 1.86% | 10.76% | 70/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 9.39% | -18.13% | 63.3% | 28/141 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 5.75% | -10.3% | 57.1% | 24/141 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 3.66% | 1.1% | -64.15% | 19/141 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 10.21% | -24.98% | -10.99% | 65/141 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 11.47% | 2.87% | 78.94% | 19/141 | 9.49% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 6.41% | 3.05% | 77.07% | 27/141 | 6.11% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 3.62% | 11.73% | -73.4% | 12/141 | 2.74% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 13.61% | 247.19% | 22.06% | 41/141 | 16.44% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 11.15% | 114.01% | 79.26% | 12/141 | 8.86% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 6.22% | 317.45% | 91.98% | 21/141 | 6.35% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | 3.24% | 109.03% | -17.35% | 10/141 | 2.3% | 健帆生物 | 7.75% | 行业排名> |